Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1

被引：6

作者：

Stickel, Felix ^{[1
]}

Worni, Mathias ^{[1
]}

Pache, Isabelle ^{[2
]}

Moradpour, Darius ^{[2
]}

Helbling, Beat ^{[3
]}

Borovicka, Jan ^{[4
]}

Gerlach, Tilman J. ^{[4
]}

机构：

[1] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland

[2] Univ Lausanne, Div Gastroenterol & Hepatol, CHUV, Lausanne, Switzerland

[3] Stadtspital Waid, Dept Gastroenterol, Zurich, Switzerland

[4] Kantonsspital, Dept Gastroenterol & Hepatol, St Gallen, Switzerland

来源：

关键词：

HCV INFECTION; PEGINTERFERON;

D O I：

10.1038/ajg.2013.140

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1176 / 1178

页数：3